Market Cap (In CNY)
6.59 Billion
Revenue (In CNY)
1.49 Billion
Net Income (In CNY)
247.69 Million
Avg. Volume
9.1 Million
- Currency
- CNY
- Country
- Healthcare
- Open
- -
- Prev. Close
- -
- Day Range
- -
- Year Range
- 5.88-9.34
- PE
- -
- EPS
- -
- Beta Value
- 0.131
- ISIN
- CNE100000L14
- CUSIP
- -
- CIK
- -
- Shares
- -
- Earnings Annoncement
- -
Company Profile
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- CEO
- Mr. Yunzhong Zhou
- Employee Count
- -
- Website
- https://www.jinghuapharm.com
- Ipo Date
- 2010-02-03
- Details
- Jinghua Pharmaceutical Group Co., Ltd. engages in the research and development, manufacture, and sale of APIs and pharmaceutical intermediates in China. Its primary products include Phenylbutazone, Primidone, Phenobarbital, Fluorouracil, Propylthiouracil, Piroxicam, and Flucytosine APIs. The company was formerly known as Nantong Jinghua Pharmaceutical Co., Ltd. Jinghua Pharmaceutical Group Co., Ltd. was founded in 1957 and is based in Nantong, China.
More Stocks
-
ABNXABIONYX Pharma SA
ABNX
-
FHB
-
MLONLSA Onlineformapro
MLONL
-
603690
-
GINNIFILAGinni Filaments Limited
GINNIFILA
-
CEFC
-
WSSTF
-
NCTKYNabtesco Corporation
NCTKY